Scholarly Index
Eugene P. Kennedy
Cellerant Therapeutics (United States); 22,192 total citations; 299 total publications; best world rank #234
Cellerant Therapeutics (United States)
22,192Total citations
299Total publications
79H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Metabolism and Genetic Disorders | Lifetime | 429 | US 191 | 98.48 |
| Enzyme Catalysis and Immobilization | Lifetime | 287 | US 52 | 98.35 |
| Amino Acid Enzymes and Metabolism | Lifetime | 279 | US 136 | 97.64 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 698 | US 307 | 98.43 |
| Lipid metabolism and biosynthesis | Lifetime | 234 | US 106 | 97.48 |
| Carbohydrate Chemistry and Synthesis | Lifetime | 663 | US 213 | 97.32 |
| Lipid Membrane Structure and Behavior | Lifetime | 682 | US 311 | 97.48 |
| Microbial Metabolic Engineering and Bioproduction | Lifetime | 918 | US 223 | 96.96 |
| Bacterial Genetics and Biotechnology | Lifetime | 894 | US 441 | 97.02 |
| Enzyme function and inhibition | Lifetime | 448 | US 225 | 93.00 |
| Biochemical Acid Research Studies | Lifetime | 498 | US 194 | 91.32 |
| Sphingolipid Metabolism and Signaling | Lifetime | 846 | US 305 | 89.98 |